Gender differences in cholinergic and dopaminergic deficits in Parkinson disease

Journal of Neural Transmission

Volumn 120, Issue 10, 2013, Pages 1421-1424

  Kotagal, Vikas ^a   Albin, Roger L ^a,b   Müller, Martijn L T M ^a   Koeppe, Robert A ^a   Frey, Kirk A ^a   Bohnen, Nicolaas I ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VAAAHS   (United States)

Author keywords

Acetylcholine; Dopamine; Gender; Parkinson disease; Women

Indexed keywords

[11 C]DIHYDROTETRABENAZINE; [11 C]PMP; ACETYLCHOLINESTERASE; CARBON 11; CHOLINERGIC RECEPTOR STIMULATING AGENT; DIHYDROTETRABENAZINE; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RATING SCALE; SEX DIFFERENCE;

BRAIN; CHOLINERGIC NEURONS; CROSS-SECTIONAL STUDIES; DOPAMINERGIC NEURONS; FEMALE; HUMANS; MALE; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; SEX CHARACTERISTICS;

EID: 84885434399     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1013-1     Document Type: Article

References (17)

1. Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, Frey KA (2006) Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab 26(9):1198-1212. doi: 10.1038/sj.jcbfm.9600276
2. Bohnen NI, Muller ML, Kotagal V, Koeppe RA, Kilbourn MR, Gilman S, Albin RL, Frey KA (2012) Heterogeneity of cholinergic denervation in Parkinson's disease without dementia. J Cereb Blood Flow Metab 32(8):1609-1617. doi: 10.1038/jcbfm.2012.60
3. de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM (2004) Incidence of Parkinsonism and Parkinson disease in a general population: the rotterdam study. Neurology 63(7):1240-1244
4. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 22(12):1689-1707. doi: 10.1002/mds.21507
5. Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, Lewitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, Lapelle N (2007) Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 22:41-47
6. Haaxma CA, Bloem BR, Borm GF, Oyen WJ, Leenders KL, Eshuis S, Booij J, Dluzen DE, Horstink MW (2007) Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry 78(8):819-824. doi: 10.1136/jnnp.2006.103788
7. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathologic study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184
8. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27(9):1533-1539. doi: 960049310.1038/sj.jcbfm.9600493
9. Jewett DM, Kilbourn MR, Lee LC (1997) A simple synthesis of [11C]dihydrotetrabenazine (DTBZ). Nucl Med Biol 24(2):197-199 pii:S0969-8051(96)00213-2
10. Koeppe RA, Frey KA, Kuhl DE, Kilbourn MR (1999) Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine. J Cereb Blood Flow Metab 19(12):1376-1384
11. Kotagal V, Albin RL, Muller ML, Koeppe RA, Chervin RD, Frey KA, Bohnen NI (2012) Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann Neurol 71(4):560-568. doi: 10.1002/ana.22691
12. Lees AJ, Hardy J, Revesz T (2009) Parkinson's disease. Lancet 373(9680):2055-2066. doi: 10.1016/s0140-6736(09)60492-x
13. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16(5):834-840
14. Miller IN, Cronin-Golomb A (2010) Gender differences in Parkinson's disease: clinical characteristics and cognition. Mov Disord 25(16):2695-2703. doi: 10.1002/mds.23388
15. Nagatsuka Si S, Fukushi K, Shinotoh H, Namba H, Iyo M, Tanaka N, Aotsuka A, Ota T, Tanada S, Irie T (2001) Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling. J Cereb Blood Flow Metab 21(11):1354-1366. doi: 10.1097/00004647- 200111000-00011
16. 11C]PMP) for in vivo measurements of acetylcholinesterase activity. Nucl Med Biol 25:751-754
17. Wong KK, Muller ML, Kuwabara H, Studenski SA, Bohnen NI (2012) Gender differences in nigrostriatal dopaminergic innervation are present at young-to-middle but not at older age in normal adults. J Clin Neurosci 19(1):183-184. doi: 10.1016/j.jocn.2011.05.013